UMIN-ICDS History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000048296
Receipt number R000054917
Scientific Title Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma
Date of disclosure of the study information 2022/09/01
Last modified on 2023/07/07 09:07:07

No. Disposal Last modified on Item of update
1 Insert 2022/07/06 10:20:59
2 Update 2023/01/06 12:49:37 Anticipated trial start date
3 Update 2023/07/07 09:07:07 Recruitment status
Date of IRB